콘텐츠 바로가기
로그인
컨텐츠
  • HOME
  • SEARCH
PLUS Text Size MINUS RESET
FACEBOOK TWITTER Linked In

Category Open

Resources

tutorial

Collection of research papers and materials on development issues

home

Resources
Industry and Technology General
Social Development Health

Print

Korean pharmaceutical industry policy : Lessons for Korea

Related Document
Frame of Image
  • Korean pharmaceutical industry policy
  • Kim, Daejung; McGuire, Alistair; Kyle, Margaret
  • Korea Institute for Health and Social Affairs


link
Title Korean pharmaceutical industry policy
Similar Titles
Sub Title

Lessons for Korea

Material Type Reports
Author(English)

Kim, Daejung; McGuire, Alistair; Kyle, Margaret

Publisher

[Sejong, South Korea] : Korea Institute for Health and Social Affairs

Date 2015
Series Title; No Research Reports / 2015-37
Subject Country South Korea(Asia and Pacific)
File Type Link
Subject Industry and Technology < General
Social Development < Health
Holding Korea Institute for Health and Social Affairs
License

Abstract

Chapter 1 introduces Korea’s pharmaceutical industry development since the 1970s. The Korean government began to recognize and grant patents on substances in 1987, which opened the industry’s eye to the R&D investment. Korean pharmaceutical companies began to develop their own new drugs, starting with Sunpla, in the 2000s. The majority of these drugs, however, exclusively targeted the domestic market and resulted in little competitiveness on a global scale. The Ministry of Health and Welfare of Korea launched the R&D Projects since 1995, As the amount of government R&D investment has been steadily rising in Korea, many have criticized the redundancy of investments made by multiple departments and agencies and the lack of interdepartmental cooperation it reflects. The key to the competitiveness of a nation’s health technology lies first and foremost in the strength and caliber of its research institutions, The factors limiting or promoting the success of academic-industrial collaboration are relatively clear. (The rest omitted)